Skip to main content
University of California San Francisco
UCSF School of Medicine | Department of Pediatrics UCSF Medical Center

5G2 mutant mice model loss of a commonly deleted segment of chromosome 7q22 in myeloid malignancies.

  • Read more about 5G2 mutant mice model loss of a commonly deleted segment of chromosome 7q22 in myeloid malignancies.

What causes aplastic anaemia?

  • Read more about What causes aplastic anaemia?

Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113 AML patients.

  • Read more about Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113 AML patients.

Classification of rare pediatric myeloid neoplasia-Quo vadis?

  • Read more about Classification of rare pediatric myeloid neoplasia-Quo vadis?

Exploring the genetic and epigenetic origins of juvenile myelomonocytic leukemia using newborn screening samples.

  • Read more about Exploring the genetic and epigenetic origins of juvenile myelomonocytic leukemia using newborn screening samples.

Loss of glucocorticoid receptor expression mediates in vivo dexamethasone resistance in T-cell acute lymphoblastic leukemia.

  • Read more about Loss of glucocorticoid receptor expression mediates in vivo dexamethasone resistance in T-cell acute lymphoblastic leukemia.

T-cell acute lymphoblastic leukemia in patients 1-45 years treated with the pediatric NOPHO ALL2008 protocol.

  • Read more about T-cell acute lymphoblastic leukemia in patients 1-45 years treated with the pediatric NOPHO ALL2008 protocol.

Fusion driven JMML: a novel CCDC88C-FLT3 fusion responsive to sorafenib identified by RNA sequencing.

  • Read more about Fusion driven JMML: a novel CCDC88C-FLT3 fusion responsive to sorafenib identified by RNA sequencing.

Downregulating Notch counteracts KrasG12D-induced ERK activation and oxidative phosphorylation in myeloproliferative neoplasm.

  • Read more about Downregulating Notch counteracts KrasG12D-induced ERK activation and oxidative phosphorylation in myeloproliferative neoplasm.

Abstract 26: RUNX1 as a transcriptional target of activated Shp2 (PTPN11) in juvenile myelomonocytic leukemia.

  • Read more about Abstract 26: RUNX1 as a transcriptional target of activated Shp2 (PTPN11) in juvenile myelomonocytic leukemia.

Pagination

  • Page 1
  • Next page ››
Subscribe to Leukemia

Pediatrics Home

MAKE A GIFT

© 2022 The Regents of the University of California. The University of California San Francisco  |  UCSF Department of Pediatrics                                                                                              Accessibility  Privacy Policy  Terms of Use  A-Z Website List